期刊文献+

铂类抗肿瘤药物的研究进展 被引量:14

The advances on platinum antitumor drugs
下载PDF
导出
摘要 目的综述铂类抗肿瘤药物的作用机制及新型铂类抗肿瘤药物的设计策略。方法查阅国内外近10年相关文献,对其进行归纳、总结,从铂类抗肿瘤药物的研究概况、作用机制及新型药物的设计策略几方面进行了介绍。结果铂类药物在抗肿瘤领域发挥着重要作用,为解决现有药物存在的耐药性、组织毒性等缺点,靶向给药、Pt(Ⅳ)模式前药、单功能团铂类抗肿瘤药物等更先进的设计策略越来越受到重视。结论铂类药物及新型铂类药物仍是抗肿瘤药物的研究热点,值得进一步研究开发。 Objective To reviewthe mechanism of platinum antitumor drugs and the newstrategies for the improvement of them. Methods The current situation,mechanism and the newdesigning strategies of platinum antitumor drugs were summarized based on the literatures in the last decade. Results Platinum agents play an important role in the field of antitumor. To overcome the problems of resistance and tissue toxicity,drug targeting and delivery,Pt( IV) model prodrugs and monofunctional platinum complexes drawmore and more attention. Conclusions Platinum antitumor drugs and the newanalogs are still a focus. It' s worthy to put more effort.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2016年第6期512-518,共7页 Journal of Shenyang Pharmaceutical University
基金 国家基础科学人才培养基金"能力提高"资助项目(J1103606) 辽宁省高校优秀人才知识计划资助项目(2013)
关键词 铂类药物 抗肿瘤 研究进展 platinum antitumor drugs review
  • 相关文献

参考文献34

  • 1ROSENBERG B,VANCAMP L.Platinum compounds:a new class of potent antitumour agents[J].Nature,1969,222(5191):385-386.
  • 2HARPER B W,KRAUSE-HEUER A M,Grant M P,et al.Advances in platinum chemotherapeutics[J].Chemistry-A European Journal,2010,16(64):7064-7077.
  • 3杨一昆,普绍平,高文桂.顺铂的应用及铂族金属抗癌药物的研究进展[J].中国新药杂志,1999,8(12):797-800. 被引量:65
  • 4WHEATE N J,WALKER S,CRAIG G E,et al.The status of platinum anticancer drugs in the clinic and in clinical trials[J].Dalton Transactions,2010,39(35):8113-8127.
  • 5FRICKER S P.Metal based drugs:from serendipity to design[J].Dalton Transactions,2007,43:4903-4917.
  • 6BOULIKAS T,PANTOS A,BELLIS E,et al.Designing platinum compounds in cancer:structures and mechanisms[J].Cancer Therapy,2007,5:537-583.
  • 7KUWAHARA A,YAMAMORI M,NISHIGUCHI K,et al.Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma[J].International Journal of Medical Sciences,2009,6(6):305-311.
  • 8BOULIKAS T,VOUGIOUKA M.Cisplatin and platinum drugs at the molecular level(review)[J].Oncology Reports,2003,10(6):1663-1682.
  • 9KASPARKOVA J,VOJTISKOVA M,NATILE G,et al.Unique properties of DNA interstrand cross‐links of antitumor oxaliplatin and the effect of chirality of the carrier ligand[J].Chemistry-A European Journal,2008,14(4):1330-1341.
  • 10林晓雯,张艳华.铂类抗肿瘤药的进展与临床评价[J].中国医院用药评价与分析,2011,11(1):4-7. 被引量:39

二级参考文献25

  • 1Alberto ME, Lucas MF, Pavelka M, et al. The secondgeneration anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism [ J ]. J Phys Chem B, 2009,113 (43) : 14473.
  • 2Kawai Y, Taniuchi S, Okahara S, et al. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation [ J ]. Biol Pharm Bull, 2005,28 (8) :1385.
  • 3Kurita H, Yamamoto E, Nozaki S,et al. Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma[ J ]. Cancer Chemother Pharmacol,2010,65 ( 3 ) :503.
  • 4Gong Y, Ren L,Zhou L, et al. Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma[J]. Cancer Chemother Pharmacol , 2009,64(2) :327.
  • 5Oshita F,Yamada K,Saito H,et al. Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer [ J ]. J Exp Ther Oncol,2004 ,4(4) :343.
  • 6Kuwahara A, Yamamori M, Nishiguchi K, et al. Replacement of cisplatin with nedaplatin in a definitive 5- fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma[ J]. Int J Med Sci,2009,6(6) :305.
  • 7Yamashita H, Nakagawa K, Tago M, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5- fluorouracil regimen: a retrospective study [ J ]. Dis Esophagus ,2006,19 ( 1 ) : 15.
  • 8Zheng J, Wang G, Yang GY, et al. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Jpn J Clin Oncol,2010,40(5):425.
  • 9Lee WS, Lee GW, Kim HW,et al. A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer[J]. Cancer Res Treat,2005,37(4) :20.
  • 10Lee KH, Hyun MS, Kim HK, et al. Randomized, multicenter,phase Ⅲ trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer [ J ]. Cancer Res Treat ,2009,41 ( 1 ) : 12.

共引文献101

同被引文献153

引证文献14

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部